BIOMAT Database Logo BIOMAT Database Logo

Cutaneous manifestation of internal malignancies (II): the sign of Leser-Trélat. 1978

B Safai, and J M Grant, and R A Good

Leser-Trélat Sign refers to a sudden showering of seborrheic keratoses and its possible relationship to internal malignancy.

UI MeSH Term Description Entries
D007642 Keratosis Any horny growth such as a wart or callus. Keratoderma Blennorrhagicum,Keratoma,Keratosis Blennorrhagica,Blennorrhagica, Keratosis,Blennorrhagicas, Keratosis,Blennorrhagicum, Keratoderma,Blennorrhagicums, Keratoderma,Keratoderma Blennorrhagicums,Keratomas,Keratoses,Keratosis Blennorrhagicas
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009182 Mycosis Fungoides A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012628 Dermatitis, Seborrheic A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS. Seborrhea,Dermatitis Seborrheica,Seborrheic Dermatitis,Dermatitides, Seborrheic,Seborrheic Dermatitides

Related Publications

B Safai, and J M Grant, and R A Good
Leser-Trélat sign as a rare manifestation of cutaneous melanoma.
June 2020, Dermatology reports,
B Safai, and J M Grant, and R A Good
Leser-Trélat Sign without Internal Malignancy.
March 2011, Case reports in oncology,
B Safai, and J M Grant, and R A Good
The sign of Leser-Trélat. A cutaneous marker for internal malignancy.
January 1985, International journal of dermatology,
B Safai, and J M Grant, and R A Good
Leser-Trélat sign.
July 2014, The Journal of the American Osteopathic Association,
B Safai, and J M Grant, and R A Good
Recurrent leser-trélat sign associated with two malignancies.
January 2002, Dermatology (Basel, Switzerland),
B Safai, and J M Grant, and R A Good
The Leser-Trélat sign.
December 2017, Cleveland Clinic journal of medicine,
B Safai, and J M Grant, and R A Good
Sign of Leser-Trélat.
July 1997, Journal of the American Academy of Dermatology,
B Safai, and J M Grant, and R A Good
Sign of Leser-Trélat.
July 1977, JAMA,
B Safai, and J M Grant, and R A Good
Sign of Leser-Trélat.
March 1978, JAMA,
B Safai, and J M Grant, and R A Good
Sign of Leser-Trélat.
January 1993, Clinics in dermatology,
Copied contents to your clipboard!